Jørgen Slots | Clinical Neuroscience |

Posted on by Neuroscientists

Prof. Dr. Jørgen Slots | Clinical Neuroscience | Best Researcher Award

Prof. Dr. Jørgen Slots, University of Southern California,  United States.

Dr. Jørgen Slots is an internationally recognized scholar in periodontology and oral microbiology, with a rich academic and professional background rooted in Denmark, the United States, and Sweden. After completing multiple advanced degrees—including a D.D.S., Ph.D., D.M.D., and M.B.A.—he held tenured and leadership roles at esteemed institutions such as the Royal Dental College, SUNYAB, and the University of Göteborg. His research focused on microbial causes of periodontal disease, bridging the gap between laboratory science and clinical treatment. Throughout his career, he has been a pioneer in integrating microbiology into dental education and has significantly influenced both teaching and clinical standards globally. His work continues to inform practices in oral health and inspire the next generation of researchers and clinicians.

Profile

Google Scholar

🎓 Early Academic Pursuits

Born in 1944 in Vejle, Denmark, Dr. Jørgen Slots embarked on a lifelong journey in dentistry and biomedical science that began at the prestigious Royal Dental College in Copenhagen. He earned his D.D.S. in 1969 and continued to delve deeper into academic excellence with an M.S. (Lic. Odont.) in 1974. His passion for periodontology led him to complete postgraduate education in this specialty by 1976, setting the stage for a research-intensive career. Not stopping there, he pursued advanced studies in microbiology at the Forsyth Dental Center in Boston, Massachusetts, where he earned a Certificate in Microbiology in 1977. By 1979, he had completed his doctoral thesis (Dr. Odont./Ph.D.), a reflection of his rigorous scientific training and commitment to academic inquiry.

🧪 Professional Endeavors in Dental Science

Dr. Slots’ career spans both private practice and academia, beginning with clinical work in Copenhagen from 1969 to 1976. However, his true calling was in academia and research, where he quickly rose through the ranks at the Royal Dental College, becoming a tenured associate professor in the Department of Periodontology and Bacteriology. His academic influence extended internationally as he moved to the United States, joining the State University of New York at Buffalo (SUNYAB) as a visiting associate professor in 1977. His multifaceted roles there included teaching, research, and graduate mentorship. In 1982, his expertise was recognized with a professorial and chair appointment at the University of Göteborg in Sweden, where he led the Department of Oral Microbiology until 1986.

🔬 Contributions and Research Focus

Dr. Slots’ core research has focused on periodontal microbiology, particularly the microbial etiology of periodontal diseases and the role of anaerobic bacteria in oral infections. His extensive background in both clinical periodontology and microbiology enabled him to bridge these disciplines, pioneering investigations into microbial pathogenesis, host responses, and antimicrobial therapy. His work at the intersection of dentistry and microbiology has contributed significantly to the understanding of how bacterial biofilms influence periodontal health and disease progression. Through his positions in leading institutions, he has mentored countless students and young researchers in translational oral biology.

🏅 Accolades and Recognition

Throughout his distinguished career, Dr. Slots has earned numerous accolades that acknowledge both his scholarly achievements and teaching excellence. His academic journey includes obtaining a D.M.D. from the University of Pennsylvania in 1986, further consolidating his clinical credentials. In 1989, he expanded his skillset by earning an M.B.A. from the Wharton School, indicating his interest in healthcare administration and leadership. Such accomplishments reflect a rare blend of scientific acumen, clinical expertise, and administrative insight that is seldom seen in one individual. His tenured appointments and leadership roles speak volumes about the respect he commands in his field.

🌍 Impact and Global Influence

Dr. Slots’ contributions have had global implications, influencing not only North American dental education but also shaping European periodontal research. His tenure at institutions in Denmark, Sweden, and the United States illustrates his international standing and thought leadership. By combining laboratory science with clinical application, he has contributed to international standards in oral hygiene practices, periodontal disease diagnostics, and treatment protocols. His collaborative work across continents has helped create a robust, evidence-based approach to periodontal care that is taught and practiced worldwide.

📚 Legacy in Dental Education and Microbiology

As a graduate faculty member and department chair, Dr. Slots played a vital role in curriculum development, graduate training, and interdisciplinary integration of oral microbiology into mainstream dental education. He has influenced a generation of oral biologists and periodontists who continue to build upon his foundational work. His teaching style, grounded in research and clinical relevance, made him a beloved educator and mentor. The ripple effects of his academic stewardship can still be seen in the progressive research and pedagogical models employed at the University of Southern California and other leading dental institutions.

🔭 Future Vision and Continuing Relevance

Though his primary academic career has matured, the legacy of Dr. Slots remains very much alive in ongoing research studies, collaborative clinical trials, and academic dialogues. His integration of clinical practice with microbiological research stands as a model for future dental scientists aiming to address emerging challenges in oral-systemic health. With a unique blend of intellectual rigor and compassionate mentorship, Dr. Slots has laid a foundation that will support future breakthroughs in both academic and applied dental sciences. His life’s work continues to inspire innovation and scientific inquiry in oral health worldwide.

Publication

Polymerase chain reaction detection of 8 putative periodontal pathogens in subgingival plaque of gingivitis and advanced periodontitis lesions
A Ashimoto, C Chen, I Bakker, J Slots – 1996

Subgingival microflora and periodontal disease
J Slots – 1979

Periodontitis: facts, fallacies and the future
J Slots – 2017

Black-pigmented Bacteroides species, Capnocytophaga species, and Actinobacillus actinomycetemcomitans in human periodontal disease: virulence factors in colonization, survival
J Slots, RJ Genco – 1984

Bacteroides gingivalis, Bacteroides intermedius and Actinobacillus actinomycetemcomitans in human periodontal diseases
J Slots, MA Listgarten – 1988

Selective medium for isolation of Actinobacillus actinomycetemcomitans
J Slots – 1982

Actinobacillus actinomycetemcomitans in Human Periodontal Disease: a Cross-Sectional Microbiological Investigation
J Slots, HS Reynolds, RJ Genco – 1980

Diabetes and periodontal diseases: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases
ILC Chapple, R Genco, Working Group 2 of the Joint EFP/AAP Workshop – 2013

The occurrence of Actinobacillus actinomycetemcomitans, Bacteroides gingivalis and Bacteroides intermedius in destructive periodontal disease in adults
J Slots, L Bragd, M Wikström, G Dahlén – 1986

Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in human periodontal disease: occurrence and treatment
J Slots, M Ting – 1999

Antibiotics in periodontal therapy: advantages and disadvantages
J Slots, TE Rams – 1990

The predominant cultivable microflora of advanced periodontitis
J Slots – 1977

Actinobacillus actinomycetemcomitans in Human Periodontal Disease: Prevalence in Patient Groups and Distribution of Biotypes and Serotypes Within Families
JJ Zambon, LA Christersson, J Slots – 1983

Systemic antibiotic therapy in periodontics
AJV Winkelhoff, TE Rams, J Slots – 1996

Microbial differences in 2 clinically distinct types of failures of osseointegrated implants
ES Rosenberg, JP Torosian, J Slots – 1991

The predominant cultivable organisms in juvenile periodontitis
J Slots – 1976

Suppression of the periodontopathic microflora in localized juvenile periodontitis by systemic tetracycline
J Slots, BG Rosling – 1983

Periodontal therapy in humans. I. Microbiological and clinical effects of a single course of periodontal scaling and root planing, and of adjunctive tetracycline therapy
J Slots, P Mashimo, MJ Levine, RJ Genco – 1979

Serology of oral Actinobacillus actinomycetemcomitans and serotype distribution in human periodontal disease
JJ Zambon, J Slots, RJ Genco – 1983

🏁 Conclusion

Dr. Jørgen Slots’ career stands as a remarkable example of interdisciplinary excellence in dental science. Through his research in periodontal microbiology, leadership in academic institutions, and dedication to global dental education, he has left a lasting legacy. His contributions have not only advanced scientific knowledge but also improved clinical approaches to oral healthcare worldwide. Dr. Slots remains a towering figure whose impact resonates in the fields of periodontology, microbiology, and beyond.

Georgia Kaiafa | Clinical Neuroscience | Best Researcher Award

Posted on by Neuroscientists

Assoc. Prof. Dr. Georgia Kaiafa | Clinical Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Georgia Kaiafa, Medical School, Aristotle University of Thessaloniki,  Greece.

Dr. Georgia Kaiafa is a distinguished hematologist and academician whose career spans clinical excellence, impactful research, and dedicated teaching. A graduate of Aristotle University of Thessaloniki, she earned her MBBS in 1987, Board Certification in Hematology in 1996, and completed her Doctorate in 2005. Her academic roles have progressed from Lecturer to Associate Professor of Hematology and Thromboembolic Diseases, with a longstanding association at AHEPA University Hospital.

Profile

Scopus

 

🎓 Early Academic Pursuits

Georgia Kaiafa began her academic journey in medicine at the prestigious Aristotle University of Thessaloniki, enrolling in the Medical School in 1980. Her foundational training was marked by determination and intellectual rigor, culminating in the completion of her MBBS in 1987. A steadfast commitment to advanced education led her to earn her Board Certification in Haematology by 1996, and later, she successfully defended her Doctorate thesis in 2005. These formative years reflect her deep-rooted passion for understanding hematological science and its clinical applications.

🧬 Professional Endeavors in Hematology

Her professional journey has been nothing short of inspiring, anchored in both clinical excellence and academic growth. Georgia Kaiafa has served in several academic ranks, beginning as a Lecturer in Hematology from 2007 to 2015, advancing to Assistant Professor until 2021, and currently holding the esteemed position of Associate Professor of Hematology and Thromboembolic Diseases. She is affiliated with AHEPA University Hospital’s Hematology Department, a major center of excellence in Greece. Her expertise was further enriched by her tenure as a Visiting Research Associate at King’s College Hospital in London in 2012, where she gained valuable international exposure. Since 2005, she has also played a leadership role as a Coordinator in the Northern Greece Office of the Health Sector, bridging academic medicine and healthcare policy.

🩸 Contributions and Research Focus

Georgia Kaiafa has devoted her scholarly efforts to advancing the understanding of thrombosis, thromboembolic disorders, and hematological malignancies. With her contributions to over 95 peer-reviewed international journal publications and participation as a Principal Investigator in 26 research trials, she has carved out a niche in evidence-based hematological research. Her investigations have deeply influenced protocols and practices in vascular pharmacology, hematologic diagnostics, and the clinical management of thrombotic conditions. She is also a prominent educator, mentoring Ph.D. candidates and contributing to postgraduate programs for both Greek and international students.

🏆 Accolades and Recognition

Her scientific contributions have not gone unnoticed. Georgia Kaiafa has received significant national acclaim, including the 1st Prize Award for Best Paper at the Pan-Hellenic Haematology Conference in 2008 and again at the 1st Conference of Internal Medicine of Northern Greece in 2015. These accolades affirm her research excellence and clinical insight. Her expertise has earned her memberships in elite national and international medical societies, including the Hellenic Stroke Organization and the European Stroke Organization, as well as a respected position in the Excellence of Thrombosis initiative.

🌍 Impact and Influence

Beyond academia and clinical service, Kaiafa has exerted influence on multiple scientific fronts. As a reviewer for prominent journals such as Thrombosis Research, Anemia, Case Reports in Hematology, and the Indian Heart Journal, she ensures high scientific standards in hematologic research worldwide. Her editorial work for both international and Greek journals demonstrates her authority in the field and her dedication to the progression of scientific communication. Her wide-ranging collaborations and committee leadership roles have significantly influenced health education and medical research in Greece and abroad.

📚 Scholarly Engagement and Mentorship

Georgia Kaiafa is not only a prolific researcher but also a passionate mentor and academic contributor. With 23 chapters in medical books, over 130 abstracts in Greek conference proceedings, and nearly 100 abstracts presented in international forums, her voice resonates across the global hematology community. She has mentored and supervised numerous doctoral students, serving on committees for 12 Ph.D. projects and directly supervising five, cultivating the next generation of scientific minds. She has also chaired 22 congress sessions and delivered more than 100 invited talks, emphasizing her respected role as both speaker and thought leader.

🔬 Legacy and Future Contributions

As a seasoned academic and clinical researcher, Georgia Kaiafa continues to shape the future of hematology in Greece and beyond. Her legacy lies in her dual commitment to clinical care and scientific discovery, especially in the realm of thromboembolic diseases and hematologic innovations. Her ongoing involvement in research protocols, editorial responsibilities, and student mentorship assures that her influence will persist. With a solid foundation and a career marked by excellence, her future contributions are likely to further impact hematological sciences and translational medicine globally.

publication

 

  • Title: Monocyte Chemoattractant Protein-1 as a Biomarker in Acute Ischemic Stroke: A Prospective Pilot Study
    Author(s): [Not specified]
    Year: 2025

 

  • Title: Prospective Study of ADAMTS13 and von Willebrand Factor’s Role in the Prediction of Outcomes in Acute Ischemic Stroke
    Author(s): [Not specified]
    Year: 2025

 

  • Title: Antiphospholipid Syndrome: A Comprehensive Clinical Review
    Author(s): [Not specified]
    Year: [Not specified]

 

  • Title: The Seasonal Distribution of Immune Thrombotic Thrombocytopenic Purpura is Influenced by Geography: Epidemiologic Findings from a Multi-Center Analysis of 719 Disease Episodes
    Author(s): [Not specified]
    Year: 2024

 

  • Title: Current Trends in Stroke Biomarkers: The Prognostic Role of S100 Calcium-Binding Protein B and Glial Fibrillary Acidic Protein
    Author(s): [Not specified]
    Year: [Not specified]

 

  • Title: Outpatient Management After Hospitalisation for Acute Decompensation of Cirrhosis: A Practical Guide
    Author(s): [Not specified]
    Year: 2024

 

  • Title: Which Is the Best Way to Treat Massive Hemoptysis? A Systematic Review and Meta-Analysis of Observational Studies
    Author(s): [Not specified]
    Year: [Not specified]

 

  • Title: Post-COVID-19 and Irritable Bowel Syndrome: A Literature Review
    Author(s): [Not specified]
    Year: [Not specified]

 

  • Title: Thyroid Disease and Systemic Lupus Erythematosus
    Author(s): [Not specified]
    Year: 2023

 

🏁 Conclusion

Dr. Georgia Kaiafa embodies the values of academic integrity, scientific advancement, and clinical leadership. Her commitment to both national healthcare development and international scientific collaboration sets her apart. With a strong foundation in research, education, and public health, she not only meets but exceeds the criteria for recognition through the Best Researcher Award. Her body of work stands as a testament to sustained excellence and future promise in hematology and related disciplines.

Liliana Elena Weimer | Clinical Neuroscience | Best Researcher Award

Posted on by Neuroscientists

Dr. Liliana Elena Weimer | Clinical Neuroscience | Best Researcher Award

Dr.  Liliana Elena Weimer, Center For Global Health Istituto Superiore di Sanita’ Rome, Italy.

Dr. Liliana Elena Weimer is a highly accomplished physician and clinical researcher , where she has risen to the prestigious Level II “First Researcher” position. Her professional focus lies in clinical trials for infectious diseases, particularly HIV and Hepatitis C. She has played a critical role in major national and international research efforts, including collaborations with the U.S. Clinical Trials Group and leadership of the large-scale PITER cohort involving 25,000 HCV patients. She is known not only for her scientific contributions but also for her humanitarian efforts during the COVID-19 emergency. Among her recognitions is the 1st Prize at the 2019 International Congress on Hepatitis C in Seville. Throughout her career, she has exemplified scientific integrity, dedication, and service to public health.

Profile

Google Scholar

🎓 Early Academic Pursuits

Born on December 19, 1965, in Buenos Aires to Italian parents, Dr. Liliana Elena Weimer embraced her dual heritage and committed herself to a life in medicine and research. With Italian citizenship and deep academic determination, she laid the groundwork for her career by studying medicine, ultimately finding her professional home in Italy. Her academic path, though not fully detailed, clearly led her toward a focus on clinical medicine and infectious diseases, with her earliest professional roles marking the beginning of a lifelong engagement in public health and biomedical research. Her intellectual dedication and international roots later became an asset in global research collaborations.

🩺 Professional Endeavors

Dr. Weimer’s distinguished career spans over three decades at the Italian National Institute of Health (ISS), beginning in 1985. Starting as a dedicated clinical physician, she ascended to Level III researcher status by 1990 and continued to grow into higher ranks, culminating in her success in the national Art. 15 competition for the Level II “First Researcher” role in 2022, officially backdated to 2021. Throughout her tenure at ISS, she became a central figure within the Global Health Center in Rome. Known for her tireless commitment, she often described her career not simply as a job but as a “mission,” emphasizing both her personal and professional passion for making a difference in human health.

🧪 Contributions and Research Focus

Specializing in clinical trials, Dr. Weimer has coordinated and participated in numerous groundbreaking studies in HIV and Hepatitis C (HCV). Since the early 1990s, she has collaborated closely with renowned figures such as Prof. Giovanni Rossi, Prof. Stefano Vella, and Prof. Gianni Rezza, contributing to some of the most pivotal HIV antiretroviral therapy trials in history. Her research efforts extended to co-leading and organizing both national and international multicenter clinical trials. Notably, she has been at the forefront of the PITER study, a major nationwide cohort that follows 25,000 patients undergoing HCV treatment—one of the most comprehensive initiatives in Italy in the fight against hepatitis.

🌍 Global Collaborations and Humanitarian Engagement

Her impact extends beyond Italy, thanks to her active involvement with the U.S.-based American Clinical Trials Group on HIV studies. These collaborations have enhanced international understanding and treatment of HIV/AIDS. In addition to her clinical and research commitments, Dr. Weimer also devoted herself to frontline service during the COVID-19 pandemic. Volunteering both with the Civil Protection unit and at Bambino Gesù Children’s Hospital, she demonstrated profound humanitarian values. Her presence during a critical time underscored her belief in serving communities not just from behind a lab desk but also on the ground, directly supporting patients and health systems under strain.

🏅 Accolades and Recognition

Dr. Weimer’s work has been acknowledged at both national and international levels. One of the most prominent recognitions she received was the 1st Prize at the International Congress on Hepatitis C held in Seville in November 2019, a testament to her excellence and influence in the field of infectious disease research. Her achievements are not only measured in accolades but also in the tangible difference her work has made in advancing therapy options and clinical management of chronic viral diseases. Her rise within the ISS and the trust placed in her leadership of major research projects further affirm her standing within the scientific community.

💡 Impact and Influence

Over the course of her extensive career, Dr. Weimer has significantly shaped clinical research strategies in Italy, especially regarding chronic viral infections. Her coordination of thousands of patient cases within structured clinical trials has informed policy decisions and improved treatment protocols nationwide. Her presence at the ISS has also influenced future generations of researchers and clinicians, many of whom benefited from her mentorship, leadership, and example of scientific integrity. Through her rigorous methods and patient-focused approach, she has played a key role in Italy’s standing as a leader in global health research, especially in relation to HIV and HCV.

🔬 Legacy and Future Contributions

Looking forward, Dr. Weimer’s contributions will continue to echo through the fields of virology and clinical medicine. Her involvement in the PITER cohort and other studies has laid down essential groundwork for long-term epidemiological surveillance and patient care strategies. With her appointment as First Researcher, she enters a new chapter of leadership, likely to drive more innovative, patient-centered research initiatives in global health. Her legacy lies not only in her publications or awards but also in the thousands of lives improved by the treatments she helped to test, refine, and implement. The combination of scientific rigor and heartfelt service defines her enduring contribution to modern medicine.

Publication

  • Outcome of sustained virological responders with histologically advanced chronic hepatitis C – TR Morgan, MG Ghany, HY Kim, KK Snow, ML Shiffman, JL De Santo, … – 2010

 

  • Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5‐year follow‐up of 150 patients – SL George, BR Bacon, EM Brunt, KL Mihindukulasuriya, J Hoffmann, … – 2009

 

  • Safety and efficacy of simeprevir/sofosbuvir in hepatitis C–infected patients with compensated and decompensated cirrhosis – V Saxena, L Nyberg, M Pauly, A Dasgupta, A Nyberg, B Piasecki, … – 2015

 

  • Slow human immunodeficiency virus type 1 evolution in viral reservoirs in infants treated with effective antiretroviral therapy – D Persaud, SC Ray, J Kajdas, A Ahonkhai, GK Siberry, K Ferguson, … – 2007

 

  • Evaluation of proton pump inhibitor use on treatment outcomes with ledipasvir and sofosbuvir in a real‐world cohort study – EB Tapper, BR Bacon, MP Curry, DT Dieterich, SL Flamm, LE Guest, … – 2016

 

  • Microbial translocation is associated with residual viral replication in HAART-treated HIV+ subjects with< 50 copies/ml HIV-1 RNA – S Baroncelli, CM Galluzzo, MF Pirillo, MG Mancini, LE Weimer, … – 2009

 

  • Predictors of failure with high-flow nasal oxygen therapy in COVID-19 patients with acute respiratory failure: a multicenter observational study – R Mellado-Artigas, LE Mujica, ML Ruiz, BL Ferreyro, F Angriman, E Arruti, … – 2021

 

  • A randomized, double-blind trial on the use of a triple combination including nevirapine, a nonnucleoside reverse transcriptase HIV inhibitor, in antiretroviral-naive patients – M Floridia, R Bucciardini, D Ricciardulli, V Fragola, MF Pirillo, LE Weimer, … – 1999

 

  • Modeling cost‐effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real‐life cohort – LA Kondili, F Romano, FR Rolli, M Ruggeri, S Rosato, MR Brunetto, … – 2017

 

  • Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER network – LA Kondili, GB Gaeta, D Ieluzzi, AL Zignego, M Monti, A Gori, A Soria, … – 2017

 

🏁 Conclusion

Dr. Weimer stands as a distinguished figure in the field of global health research, with deep expertise in clinical trials and infectious diseases. Her legacy is marked by landmark contributions to HIV and HCV treatment protocols, influential collaborations, and compassionate public service. Her ongoing work continues to shape public health policy and medical research in Italy and beyond. As she advances in her leadership role at the ISS, her experience, insight, and dedication will remain vital to future innovations in clinical research and global health.

Ayman M. Ibrahim | Neurochemistry | Best Academic Researcher Award

Posted on by Neuroscientists

Mr. Ayman M. Ibrahim | Neurochemistry | Best Academic Researcher Award

Mr. Ayman M. Ibrahim,  Department of Mining Engineering, University of Nyala, Sudan.

Ayman Mohamed Hassan Ibrahim is a dedicated researcher and academic in the field of mineral processing and mining engineering, with over nine years of experience in Chinese and Sudanese academic institutions. Holding a Ph.D. in Mineral Processing Engineering, he is currently serving as an Assistant Professor at the University of Nyala and a Postdoctoral Researcher at Kunming University of Science and Technology. His academic journey reflects a deep commitment to innovation, sustainability, and the advancement of mineral extraction technologies. Ayman has made notable contributions to the scientific understanding of malachite flotation, publishing extensively in SCI-indexed journals and engaging in international collaborations. Fluent in Arabic, English, and Chinese, he bridges cultural and scientific boundaries, mentoring students and influencing sustainable mining practices across borders.

Profile

Google Scholar
Orcid
Scopus

🎓 Early Academic Pursuits

Ayman Mohamed Hassan Ibrahim’s journey into the world of mineral engineering began with a strong academic foundation. He earned his Bachelor of Science in Mining Engineering from Omdurman Islamic University in 2012, which laid the groundwork for his passion in geosciences and mineral technology. His academic drive led him to pursue a Master of Science in Mining Technology at the Sudan Academy of Sciences, graduating in 2017. He then earned his Ph.D. in Mineral Processing Engineering in June 2023, where he delved deeply into sustainable solutions for the mining industry. His early academic experiences were characterized by curiosity, discipline, and an eagerness to contribute to real-world challenges in mineral extraction and processing.

👨‍🏫 Professional Endeavors

Professionally, Ayman’s career has grown through diverse academic and research roles. He began his teaching journey as a Teaching Assistant at Nyala University from 2013 to 2015. Demonstrating both leadership and technical expertise, he was promoted to Lecturer at the University of Nyala between 2017 and 2018. In June 2023, he returned to the university as an Assistant Professor, where he currently teaches mineral engineering and engineering geology. He also contributes part-time as an instructor at the University of Khartoum, mentoring postgraduate students. Concurrently, Ayman holds a prestigious Postdoctoral Researcher position at Kunming University of Science and Technology, China, where he collaborates on cutting-edge projects addressing global mineral processing and sustainability challenges.

🔬 Contributions and Research Focus

Ayman’s research focus lies at the intersection of mineral processing, flotation chemistry, and environmentally sustainable mining practices. His work emphasizes enhancing flotation recovery and developing eco-friendly reagents and technologies. He is especially recognized for his contributions to the sulfurization flotation of malachite. His recent publications explore the role of novel reagents like thiourea and ammonium sulfide, investigating their performance in enhancing copper recovery. Through advanced analytical techniques like XPS, FTIR, and ToF-SIMS, Ayman’s research not only increases flotation efficiency but also deepens the mechanistic understanding of mineral surface interactions.

🏅 Accolades and Recognition

Throughout his academic and professional career, Ayman has built a reputation as a dynamic and impactful researcher. His work is published in several high-impact SCI-indexed journals, including Colloids and Surfaces A and Physicochemical Problems of Mineral Processing. These achievements reflect both the novelty and practical value of his contributions. His ability to conduct independent research, collaborate internationally, and publish in leading journals demonstrates his standing within the global mineral engineering community. His scientific insights are also widely recognized in academic conferences and professional forums, further enhancing his credibility and scholarly presence.

🌍 Impact and Influence

Ayman’s influence goes beyond academia. As a bridge between research and industry, he actively fosters academia-industry collaborations, targeting practical challenges in mineral recovery and resource efficiency. His work contributes directly to developing sustainable practices within mining enterprises, particularly in China and Sudan. By mentoring students, supervising postgraduate research, and participating in capacity-building initiatives, he plays a vital role in empowering the next generation of mining and geology professionals. His ability to fluently communicate in Arabic, English, and Chinese enhances his global connectivity and multidisciplinary impact.

🚀 Legacy and Future Contributions

Looking ahead, Ayman is poised to become a thought leader in sustainable mineral processing. His ongoing postdoctoral research in China signifies his dedication to international collaboration and scientific advancement. His vision includes innovating green technologies for mineral extraction, improving resource utilization, and integrating advanced surface chemistry with engineering practices. As a committed educator and researcher, Ayman aims to influence policy, research, and practice in sustainable mining, leaving behind a legacy of knowledge, innovation, and community advancement.

🧪 Passion for Scientific Innovation

At the core of Ayman Mohamed Hassan Ibrahim’s journey is a passion for discovery and innovation in mineral engineering. Whether through his analytical skills using tools like ARC GIS, Origin, and XPS, or his strategic approach to project management and academic writing, Ayman exemplifies the qualities of a forward-thinking researcher. His focus on improving flotation technologies and reducing environmental footprints reflects a deep commitment to both science and sustainability. As he continues to explore new frontiers in mineral processing, Ayman stands as a model of how science can be harnessed for the betterment of both industry and society.

Publication

  • Title: Improved activation of malachite sulfurization flotation by thiourea’s (CS(NH2)2): Performance and mechanism study
    Authors: Ayman M. Ibrahim; Han Wang; Jaber A. Yousif; Mohammed Elhadi; Peilun Shen; Dianwen Liu
    Year: 2024

 

  • Title: A Case Report on Cyanidation of Gold Heap Tailings at Agbash Mine in South Darfur State (Sudan)
    Author: Ayman M H Ibrahim
    Year: 2023

 

  • Title: Effect of lead ions on accidental adsorption of Calcium Lignosulphonate on chalcopyrite surface
    Authors: Su, Chao; Pei, Bin; Ibrahim, Ayman M.; Jia, Xiaodong; Cai, Jinpeng; Shen, Peilun; Liu, Dianwen
    Year: 2023

 

  • Title: Effect of pre-oxidation on copper-lead bulk concentrate flotation separation with sodium polyacrylate as galena depressant
    Authors: Cai, Jinpeng; Jia, Xiaodong; Ma, Yinyu; Ibrahim, Ayman M.; Su, Chao; Yu, Xingcai; Shen, Peilun; Liu, Dianwen
    Year: 2023

 

  • Title: Role of ammonium phosphate in improving the physical characteristics of malachite sulfidation flotation
    Authors: Ibrahim, Ayman M.; Jia, Xiaodong; Cai, Jinpeng; Su, Chao; Yu, Xingcai; Zheng, Qifang; Peng, Rong; Shen, Peilun; Liu, Dianwen
    Year: 2023

 

  • Title: Effect of Ammonium Sulfide on Sulfidization Flotation of Malachite
    Authors: Ibrahim, Ayman M.; Jia, Xiaodong; Su, Chao; Cai, Jinpeng; Shen, Peilun; Liu, Dianwen
    Year: 2022

 

  • Title: Separation of copper-sulfur using sodium polyacrylate as pyrite depressant in acidic pulp: Floatability and adsorption studies
    Author: Ayman Mohamed Hassan Ibrahim
    Year: 2022

 

🧾 Conclusion

Dr. Ayman Ibrahim’s career is a testament to the power of persistence, scientific rigor, and global collaboration. His research not only enhances mineral recovery technologies but also contributes meaningfully to environmental sustainability in the mining sector. As he continues his work in academia and postdoctoral research, Ayman is set to play a pivotal role in shaping the future of mineral processing through innovative solutions and impactful education. His legacy is being built not only through publications and projects but also through the minds he inspires and the communities he serves.

Katherine Mandeville | Clinical Neuroscience | Best Researcher Award

Posted on by Neuroscientists

Dr. Katherine Mandeville | Clinical Neuroscience | Best Researcher Award

Dr. Katherine Mandeville, University of California San Diego, United States.

Dr. Katherine Mandeville is a distinguished pediatric emergency physician and academician whose career reflects a commitment to excellence in both clinical care and research. With a strong academic foundation in biochemistry and medicine from the University of New Mexico, she pursued advanced clinical training at leading institutions such as the University of Colorado and Phoenix Children’s Hospital. Her academic and clinical trajectory has led her to a prominent role at the University of California, San Diego (UCSD), where she serves as an Associate Clinical Professor in the Department of Pediatrics, Division of Emergency Medicine at Rady Children’s Hospital.

Profile

Scopus
Orcid

 

🎓 Early Academic Pursuits

Dr. Katherine Mandeville’s journey into the medical field was rooted in a solid foundation in science and critical inquiry. She began her academic path studying biochemistry and chemical engineering at the University of New Mexico, where she also explored non-degree coursework at Albuquerque Technical Vocational Institute. Her early academic versatility revealed a strong analytical mindset and a deep interest in human health and systems. In 1999, she earned her Medical Degree from the University of New Mexico School of Medicine, setting the stage for a career centered on both patient care and research-driven excellence.

🩺 Professional Endeavors

Following her graduation from medical school, Dr. Mandeville pursued intensive clinical training at the University of Colorado Health Sciences Center, where she completed her pediatric internship, residency, and advanced to a fellowship in Pediatric Emergency Medicine at Phoenix Children’s Hospital. These formative experiences immersed her in the fast-paced, high-stakes environment of emergency pediatrics. Since joining the University of California, San Diego (UCSD), she has progressed from Associate to Assistant and now Associate Clinical Professor within the Department of Pediatrics, Division of Emergency Medicine at Rady Children’s Hospital. Her clinical role complements her academic responsibilities, fostering a dual commitment to exceptional care and education.

🔬 Contributions and Research Focus

Dr. Mandeville’s research trajectory is marked by a keen interest in bridging clinical care and evidence-based medicine. Her decision to pursue a Master of Science in Clinical Research at the University of New Mexico’s Health Sciences Center demonstrates a deliberate move toward translational science and healthcare innovation. Her work integrates real-world clinical challenges in pediatric emergency departments with scientific inquiry, focusing on improving outcomes for vulnerable pediatric populations. While her biography does not specify individual research projects or publications, her advanced training and consistent academic appointments suggest active involvement in research development, collaborative studies, or clinical protocols aimed at advancing pediatric emergency medicine.

🏆 Accolades and Recognition

Dr. Mandeville’s credentials reflect longstanding recognition in the field of pediatrics. She is certified by the American Board of Pediatrics in both General Pediatrics and Pediatric Emergency Medicine—a rare and prestigious combination. Her sustained licensure in California and prior credentials in Nevada highlight her clinical credibility, while her affiliation with institutions such as UCSD and Rady Children’s Hospital place her in nationally ranked centers of pediatric care. The progression of her academic titles further underscores institutional trust in her leadership, mentorship, and research capabilities.

🌍 Impact and Influence

Throughout her career, Dr. Mandeville has consistently served at the intersection of medicine, mentorship, and systemic impact. At Rady Children’s Hospital—a major referral center in Southern California—she has influenced both the quality of emergency pediatric care and the professional development of young physicians. Her expertise and clinical judgment are undoubtedly shaping the training experiences of future pediatricians, residents, and fellows. Moreover, her presence in a teaching hospital and research-driven university ensures that her influence extends beyond clinical settings into broader academic and public health circles.

🔗 Legacy and Future Contributions

Dr. Mandeville is well-positioned to leave a lasting legacy in pediatric emergency care and clinical education. With her strong academic background, research training, and high-level clinical experience, she represents the next generation of clinician-researchers dedicated to evidence-based improvements in pediatric health. Her ongoing work at UCSD is likely to contribute to innovations in emergency care delivery, interdisciplinary teaching, and policy development in children’s health services. As medical systems increasingly prioritize translational research and quality improvement, her dual role as educator and researcher will only grow more pivotal.

🧪 Commitment to Research-Driven Medicine

What sets Dr. Mandeville apart is her integration of research training into her clinical identity. The MSCR program she completed reflects a structured and methodical approach to data analysis, study design, and outcomes research—skills that are vital in transforming bedside observations into peer-reviewed evidence. While not all research is visible in public citations, her long-term affiliation with academic medical centers and role in an evidence-based specialty suggests a strong alignment with research objectives. Her career embodies the principle that the best medical care is informed by rigorous scientific investigation, continuous learning, and collaborative innovation.

Publication

  • Title: Effects of Timing to Diagnosis and Appendectomy in Pediatric Appendicitis
    Author(s): Mandeville K, Monuteaux M, Pottker T, Bulloch B
    Year: 2015

 

  • Title: The Frequency of Postreduction Interventions After Successful Enema Reduction of Intussusception
    Author(s): Lessenich EM, Kimia AA, Mandeville K, Li J, Landschaft A, Tsai A, Bachur R
    Year: 2015

 

  • Title: Intussusception: Clinical Presentations and Imaging Characteristics
    Author(s): Mandeville K, Chien M, Willyerd FA, Mandell G, Hostetler MA, Bulloch B
    Year: 2012

 

  • Title: Management of the Child After Enema-Reduced Intussusception: Hospital or Home?
    Author(s): Chien M, Willyerd FA, Mandeville K, Hostetler MA, Bulloch B
    Year: 2012

 

  • Title: Using Appendicitis Scores in the Pediatric ED
    Author(s): Mandeville K, Pottker T, Bulloch B, Liu J
    Year: 2010

 

  • Title: Brain Oxygen Utilization Is Unchanged by Hypoglycemia in Normal Humans: Lactate, Alanine, and Leucine Uptake Are Not Sufficient to Offset Energy Deficit
    Author(s): Lubow JM, Piñón IG, Avogaro A, Cobelli C, Treeson DM, Mandeville KA, Toffolo G, Boyle PJ
    Year: 2005

 

  • Title: Presentation, Evaluation, and Outcomes of Infants Under Three Months With Skull Fractures
    Author(s): Mandeville K
    Year: Not specified (date not provided in source)

 

🏁 Conclusion

Dr. Katherine Mandeville exemplifies the role of a clinician-researcher in modern medicine. Her robust educational background, commitment to pediatric emergency care, and pursuit of research-driven solutions have positioned her as a valuable leader in her field. Her influence spans clinical innovation, academic mentorship, and systemic healthcare improvements, making her a key contributor to both pediatric patient outcomes and medical education. As she continues her work at UCSD and Rady Children’s Hospital, her legacy is poised to grow through impactful research, mentorship, and advocacy for best practices in pediatric emergency medicine.

Daon Hwang | Clinical Neuroscience | Best Researcher Award

Posted on by Neuroscientists

Mr. Daon Hwang | Clinical Neuroscience | Best Researcher Award

Mr. Daon Hwang,  Depatment of Physical Therapy, Korea Natiional University of Transportation,  South Korea.

Daon Hwang is a dedicated physical therapist and Ph.D. candidate at Korea National University of Transportation, with a strong academic and clinical foundation in adult neurological rehabilitation. His research portfolio includes six completed projects and six peer-reviewed publications, focusing on stroke rehabilitation, gait analysis, neurorehabilitation, and assistive device development. With a practical background in clinical therapy and consulting experience in device usability, he effectively bridges the gap between research and real-world application. His active involvement in professional organizations further enriches his contributions to the rehabilitation field.

Profile

Orcid

🎓 Early Academic Pursuits

Daon Hwang began his academic journey with a deep interest in the human body and its recovery mechanisms, leading him to pursue a career in physical therapy. He earned both his Bachelor’s and Master’s degrees in Physical Therapy from Korea National University of Transportation (KNUT). His early academic years were marked by diligence and a curiosity-driven approach to the complexities of neurological rehabilitation. His strong academic performance and growing passion for evidence-based practice set the stage for his current doctoral research.

💼 Professional Endeavors

As a licensed physical therapist, Daon Hwang has accumulated meaningful clinical experience, particularly in the field of adult neurological rehabilitation. His hands-on work with stroke patients has fueled his commitment to integrating practical therapy with innovative research. His current role as a Ph.D. candidate at KNUT allows him to bridge clinical practice with academic exploration, where he also provides consultancy on assistive devices. Daon continues to evolve both as a practitioner and as a scholar in the rehabilitation sciences.

🧠 Contributions and Research Focus

Daon’s primary research focuses include stroke rehabilitation, neurorehabilitation, gait analysis, and the development of assistive technologies. He has successfully completed six research projects, exploring diverse aspects such as proprioceptive training and the usability of rehabilitation devices. His scholarly output includes six peer-reviewed journal publications—two in SCI-indexed journals and four in KCI-indexed journals. These works contribute to enhancing therapeutic protocols and improving patients’ functional outcomes, particularly in post-stroke recovery.

🧪 Research Innovation and Impact

Daon’s innovative contributions are evident in his work with assistive device usability, having collaborated on three industry consulting projects to improve device design and user experience for stroke patients. His research has not only advanced academic knowledge but also offered real-world applicability in clinical settings. His studies often highlight the integration of biomechanical analysis and rehabilitation techniques to create more personalized and effective interventions.

🏅 Accolades and Professional Involvement

While Daon Hwang has not yet published books or acquired patents, his membership in several esteemed professional bodies reflects his dedication to continued learning and contribution to the field. He is an active member of the Korean Academy of Orthopedic Manipulative Physical Therapy, the Korean Physical Therapy Association, and the Korea Proprioceptive Neuromuscular Facilitation Association. Through these affiliations, he stays at the forefront of developments in physical therapy and rehabilitation science.

🌍 Influence and Collaboration

Though he has not formally reported collaborative research projects, Daon’s consulting work and clinical partnerships demonstrate a growing sphere of influence. His findings are increasingly referenced by peers and practitioners, particularly in the areas of gait mechanics and neuro-motor rehabilitation. His dual role in academia and practice ensures his research remains grounded in clinical relevance.

🔮 Legacy and Future Contributions

Looking ahead, Daon Hwang aspires to further integrate technology with neurorehabilitation strategies, aiming to develop more efficient, adaptive tools for stroke survivors. His doctoral work and future post-doctoral goals center on refining rehabilitative methods through data-driven research and interdisciplinary collaboration. With a vision of contributing meaningfully to global rehabilitation science, Daon is poised to leave a lasting legacy of innovation, empathy, and excellence in physical therapy.

Publication

  • Title: Usability Test for an Over-Ground Walking Assistance Robotic Device Based on the Mecanum Wheel
    Authors: Daon Hwang; EunPyeong Choi; Ki Hun Cho
    Year: 2025

 

  • Title: Changes in Balance Ability, Physical Performance and Lower Extremity Proprioception according to the Compression Stockings in University Students
    Authors: Daon Hwang; Hyeong Gyu Kim; Na Young Kang; Eun Seo Park; Hyun Young Yoo; Jun Young Lee; Seo Yeong Jang; Cheol Woo Hwang; Ki Hun Cho
    Year: 2025

 

  • Title: Usability Test for a Cane-Combined Weight Support Feedback Device
    Authors: Daon Hwang; Ki Hun Cho
    Year: 2024

 

  • Title: Usability Test for Motion Tracking Gait Assistive Walker
    Authors: Daon Hwang; Ki Hun Cho
    Year: 2023

 

  • Title: The Effect of Mirror Therapy on the Balance, Gait and Motor Function in Patients with Subacute Stroke: A Pilot Study
    Authors: Min-Su Song; Soon-Hee Kang
    Year: 2021

 

  • Title: Effect of Mirror Therapy on the Balance, Gait and Motor Function in Patients with Subacute Stroke
    Authors: Min-Su Song; Soon-Hee Kang
    Year: 2021

 

✅ Conclusion

Driven by a passion for enhancing recovery outcomes in stroke patients, Daon Hwang has positioned himself as a promising scholar and practitioner in the field of physical therapy. His blend of academic rigor, clinical expertise, and innovation in assistive technologies reflects a career marked by meaningful impact and ongoing growth. As he advances toward completing his Ph.D., his work continues to shape the future of neurorehabilitation—promoting evidence-based practices and contributing to patient-centered healthcare innovations.

stefano | Clinical Neuroscience | Innovative Research Award

Posted on by Neuroscientists

Dr. Stefano | Clinical Neuroscience | Innovative Research Award

Dr. Stefano, Ospedale Santa Chiara Trento, Italy.

Dr. Stefano Branzoli is a highly accomplished cardiac surgeon with decades of experience spanning Italy, Belgium, and the United States. After completing his medical studies at the University of Pavia, he advanced through elite international training, including a fellowship at the Mayo Clinic. His career has focused on surgical innovation in cardiac electrophysiology, with particular emphasis on thoracoscopic ablation for atrial fibrillation, stroke prevention, and ventricular arrhythmias. Through his roles at Santa Chiara Hospital and Universitair Ziekenhuis Brussel, he has contributed extensively to both clinical practice and academic research.

Profile

Orcid

🧬 Early Academic Pursuits


Dr. Stefano Branzoli began his journey into medicine at the prestigious University of Pavia, where he earned his degree in Medicine and Surgery between 1992 and 1998. Driven by a deep curiosity for cardiovascular science, he embarked on rigorous postgraduate training, marking the start of an extraordinary career in cardiac surgery. His academic excellence soon opened international doors, including a coveted fellowship at the Mayo Clinic in Rochester, Minnesota.

🏥 Professional Endeavors


From 1999 to 2004, Dr. Branzoli honed his clinical expertise as a resident in cardiac surgery at the University of Pavia. He became board-certified after completing the USMLE in 2000, equipping him with transatlantic qualifications. Since 2005, he has served in the Cardiac Surgery Unit at Santa Chiara Hospital in Trento, Italy, while also expanding his reach as a specialist at the Universitair Ziekenhuis Brussel in Belgium since 2019. These dual roles reflect his commitment to advancing surgical standards across borders.Contributions to Cardiac ElectrophysiologyThroughout his career, Dr. Branzoli has been instrumental in the development and refinement of procedures targeting arrhythmias. His clinical and research contributions in thoracoscopic ablation for atrial fibrillation, stroke prevention, and epicardial ablation for ventricular arrhythmias have positioned him as a leading voice in electrophysiological cardiac surgery. He has been particularly focused on minimally invasive techniques that reduce patient recovery time while enhancing procedural efficacy.

🔬 Research Focus and Innovation


Dr. Branzoli’s research portfolio reflects his dedication to solving complex cardiovascular challenges. He has led and contributed to significant projects centered on atrial fibrillation, stroke prevention strategies, and novel ablative techniques. His work bridges the gap between traditional surgical approaches and cutting-edge electrophysiological interventions, helping shape the future of cardiac care through both clinical practice and investigative science.

🏅 Accolades and Recognition


Though modest in demeanor, Dr. Branzoli’s accomplishments have earned him respect in academic and clinical circles alike. His training at the Mayo Clinic—a global epicenter for cardiac research—along with his dual appointments in Italy and Belgium, speak volumes of his international reputation. His involvement in advanced cardiac rhythm management has earned recognition from peers and institutions aiming to elevate surgical excellence.

🌍 Impact and Influence


Beyond the operating theater, Dr. Branzoli’s influence is reflected in the widespread adoption of thoracoscopic ablation techniques and his mentorship of upcoming cardiac surgeons in Europe. By integrating cross-border expertise, he has played a vital role in aligning surgical standards and promoting collaborative research between institutions in Italy, Belgium, and beyond.

🔮 Legacy and Future Contributions


As medicine evolves toward personalized, minimally invasive therapies, Dr. Branzoli stands at the forefront of surgical innovation. His work continues to inspire new pathways in arrhythmia management and stroke prevention. With a career spanning continents and a mind open to continual learning, his legacy is defined not only by lives saved but also by knowledge passed on to future generations of cardiovascular specialists.

Publication

  • Title: Patients with Gastrointestinal Bleeding and Atrial Fibrillation: Potential Ideal Target for Epicardial Appendage Occlusion
    Authors: Stefano Branzoli, Massimiliano Marini, Domenico Catanzariti, Cecilia Pravadelli, Luigi Pannone, Giovanni D’Onghia, Mauro Fantinel, Fabrizio Guarracini, Gaia Franceschini, Mirco Zadro et al.
    Year: 2025

 

  • Title: Heart Team for Left Appendage Occlusion without the Use of Antithrombotic Therapy: The Epicardial Perspective
    Authors: Stefano Branzoli, Fabrizio Guarracini, Massimiliano Marini, Giovanni D’Onghia, Domenico Catanzariti, Elettra Merola, Luciano Annicchiarico, Giulia Casagranda, Chiara Stegagno, Mauro Fantinel et al.
    Year: 2022

 

✅ Conclusion


Dr. Branzoli’s enduring commitment to advancing cardiac surgery has had a meaningful impact on patient care, research, and education. With a legacy rooted in innovation, cross-cultural collaboration, and a passion for arrhythmia management, he continues to influence the evolving field of cardiovascular medicine. His work serves as a bridge between traditional surgical methods and modern electrophysiological therapies—ensuring that the future of heart care is not only safer and more effective but also profoundly human-centered.

Abdullah Alghamdi | Emerging Areas in Neuroscience | Best Researcher Award

Posted on by Neuroscientists

Mr. Abdullah Alghamdi | Emerging Areas in Neuroscience | Best Researcher Award

Mr. Abdullah Alghamdi, University of Birmingham (UK) and Taibah University (Saudi Arabia),  United Kingdom.

Eng. Abdullah A. Zohaid (SMIEEE, SMIET) is an accomplished electrical engineer and academic with a specialization in Smart Power Systems, focusing on electric vehicles, AI-integrated transportation systems, and sustainable smart city infrastructure. With a solid educational foundation—earning distinctions at every academic level—he has seamlessly merged academic excellence with real-world engineering experience. From his early career at Saudi Aramco to his dual lecturing roles at Taibah University and the University of Birmingham, Abdullah has built a reputation as a forward-thinking researcher, educator, and strategist. His work bridges technical innovation with societal needs, aiming to optimize power grids and energy systems for a sustainable future.

Profile

Google Scholar

🎓 Early Academic Pursuits

From the historic city of Medina, Saudi Arabia, Eng. Abdullah A. Zohaid embarked on his academic journey in Electrical Engineering at Taibah University, where his talent and determination earned him distinction in his final project. His academic passion soon carried him to the United Kingdom, where he pursued an MSc in Electrical Power Systems at the University of Birmingham, graduating with First-Class Honors and distinction. Abdullah’s unwavering commitment to academic excellence continued as he embarked on a Ph.D. in Smart Power Systems at the same institution. Excelling in all areas, he has distinguished himself through both research prowess and scholastic achievement.

⚡ Professional Endeavors

Eng. Alghamdi has established himself as a dynamic professional straddling the worlds of academia and industry. His journey began with Saudi Aramco’s Dodsal Company, contributing to the vital 56″ Gas Pipeline project as an assistant electrical engineer. He transitioned into academia with his role as a Lecturer at Taibah University in Yanbu and later joined the University of Birmingham as a faculty member. Balancing dual academic roles in Saudi Arabia and the UK, Abdullah has developed a unique global perspective, blending practical engineering insight with cutting-edge educational delivery. His presence as an educator underscores his belief in empowering future engineers with real-world readiness.

🔬 Contributions and Research Focus

A scholar deeply embedded in the future of sustainable power, Eng. Alghamdi’s research focuses on Smart Power Systems, electric vehicles, smart charging infrastructures, and the integration of AI in intelligent transportation systems. Through his ongoing Ph.D. research, he explores how emerging technologies can enhance smart grid resilience and contribute to the development of smart cities. He utilizes advanced simulation and optimization tools such as MATLAB/SIMULINK, Python, and Gurobi, combined with machine learning techniques (ANN/CNN), to propose innovative solutions that address pressing energy challenges. His passion for sustainability is evident in his contributions to the global energy discourse, especially in urban mobility and decarbonization.

🏆 Accolades and Recognition

Eng. Zohaid’s career is adorned with recognition and academic milestones. His consistent distinction in every academic phase, including honors during both his MSc and Ph.D. studies, reflects a sustained trajectory of excellence. As a senior member of prestigious engineering bodies like IEEE and IET, and a certified Professional Engineer by the Saudi Council of Engineers, his credentials are a testament to his standing in the professional community. Furthermore, his publications in Q1 journals and contributions to leading international conferences validate the depth of his research and the quality of his scholarly communication.

🌍 Impact and Influence

With affiliations across IEEE working groups and university research circles, Eng. Alghamdi’s influence spans global academic and professional spheres. As a presenter and contributor at numerous high-level conferences — from the IEEE Power & Energy Society to Net Zero Futures and Saudi Innovation events — he has played a key role in shaping conversations on smart energy. His multidisciplinary expertise allows him to drive collaborations across AI, optimization, and power systems, impacting both policy and practice. His ability to simplify complex engineering concepts and communicate them effectively has enabled him to become a trusted voice among peers and students alike.

💡 Innovation and Strategic Vision

Abdullah’s strength lies in visionary thinking and strategic problem-solving. He doesn’t merely research problems—he crafts systems and strategies that reflect future-forward thinking. His approach to sustainable urban infrastructure blends technological acumen with strategic planning, leadership, and innovation. As an educator and researcher, he fosters environments that promote critical thinking and team-based innovation, cultivating the next generation of engineers equipped to face tomorrow’s challenges. His work on smart charging and intelligent transportation embodies the essence of transformative impact through design thinking and systems innovation.

🚀 Legacy and Future Contributions

Looking ahead, Eng. Abdullah A. Zohaid is poised to leave a lasting legacy in the realm of smart power systems and urban sustainability. His dual role as a lecturer and researcher gives him a powerful platform to shape both academic knowledge and real-world applications. With his continued focus on electrification, smart mobility, and AI-driven infrastructure, he is on track to influence policy, inspire innovation, and expand the boundaries of what is possible in modern power systems. His legacy will be defined not only by the technologies he helps build but also by the students and professionals he inspires along the way.

Publication

  • Innovative Prepositioning and Dispatching Schemes of Electric Vehicles for Smart Distribution Network Resiliency and Restoration
    AAM Alghamdi, D. Jayaweera, 2022

 

  • Resilience of Modern Power Distribution Networks with Active Coordination of EVs and Smart Restoration
    AAM Alghamdi, D. Jayaweera, 2023

 

  • Modelling Frameworks Applied in Smart Distribution Network Resiliency and Restoration
    AAM Alghamdi, D. Jayaweera, 2022

 

  • Resilience-Oriented Restoration in Modern Power Distribution Networks with Smart Electric Vehicles Coordination Framework
    A. Alghamdi, D. Jayaweera, 2023

 

  • Risk and Resilience Based Residential Electric Vehicle Integration Framework for Restoration of Modern Power Distribution Networks
    A. Alghamdi, D. Jayaweera, 2025

 

  • Electric Boats and Electric Vehicles Data-Driven Approach for Enhanced Resilience in Power Distribution Networks
    AAM Alghamdi, D. Jayaweera, 2025

 

✅ Conclusion

Eng. Alghamdi stands at the forefront of energy transformation, using research, innovation, and teaching as tools to drive meaningful change. His contributions reflect a blend of technical mastery and visionary leadership, enabling progress in smart mobility, clean energy, and intelligent infrastructure. With a growing portfolio of Q1 publications, prestigious memberships, and impactful conference roles, he continues to influence the field of electrical engineering on a global scale. As he advances in his career, his legacy will be marked by both technological advancements and the future minds he mentors—solidifying his role as a transformative figure in the evolution of smart power systems.

Che Ping Cheng | Translational Neuroscience | Best Researcher Award

Posted on by Neuroscientists

Prof. Che Ping Cheng | Translational Neuroscience | Best Researcher Award

Prof. Che Ping Cheng, Wake Forest University School of Medicine, United States.

Dr. Che Ping Cheng, M.D., Ph.D., FAHA, is a distinguished cardiovascular physiologist and internal medicine specialist whose career has been dedicated to advancing the understanding of heart function and failure. From earning his medical degree in China to completing a Ph.D. in Physiology at Wayne State University, and later conducting pivotal postdoctoral research at Wake Forest School of Medicine, Dr. Cheng has consistently pursued excellence in science and education. His research on ventricular mechanics, volume loading, and heart failure has significantly influenced both experimental cardiology and clinical practice. Recognized as a Fellow of the American Heart Association, he is also a dedicated mentor, shaping the next generation of cardiovascular researchers through his academic leadership.

Profile

Scopus

 

🎓 Early Academic Pursuits

Dr. Che Ping Cheng’s journey into medicine and science began in Nanjing, China, where he earned his M.D. degree from Nanjing Railway Medical University in 1977. His early academic path reflected a deep interest in understanding the intricacies of human health, particularly in cardiovascular physiology. Driven by a desire to expand his knowledge and research capabilities, Dr. Cheng pursued his Ph.D. in Physiology at Wayne State University School of Medicine in Detroit, Michigan, completing his degree in 1986. Under the mentorship of Dr. Robert S. Shepard, his doctoral work focused on exploring the mechanisms of cardiovascular response to volume loading in a canine model with tricuspid valvulectomy, setting a strong foundation for his lifelong focus on heart function and disease mechanisms.

🩺 Professional Endeavors

Following his academic training, Dr. Cheng embarked on postdoctoral studies at the Bowman Gray School of Medicine (now part of Wake Forest School of Medicine), where he continued to cultivate his expertise in internal medicine and cardiovascular physiology. Between 1986 and 1988, he served as a Postdoctoral Fellow under the guidance of Dr. William C. Little. His research during this period focused on ventricular dynamics and the physiological factors affecting active ventricular filling, which would later inform his broader work on heart failure and cardiac function. Dr. Cheng has since remained at Wake Forest School of Medicine, where he is currently a distinguished member of the Section on Cardiovascular Medicine.

🧪 Contributions and Research Focus

Dr. Cheng’s career has been characterized by a deep commitment to advancing the understanding of cardiac hemodynamics, ventricular interaction, and heart failure mechanisms. His research has explored how ventricular function responds under altered physiological states, and how these responses inform disease progression and treatment strategies. His early animal model studies have provided critical insights into the interplay between structural and functional changes in the heart, especially in the context of diastolic dysfunction and volume overload conditions. Dr. Cheng has also made significant strides in translating these findings to clinical contexts, influencing how cardiologists approach diagnosis and therapy.

🏅 Accolades and Recognition

Throughout his career, Dr. Cheng has received considerable recognition for his scholarly contributions. He is a Fellow of the American Heart Association (FAHA), an honor that reflects his standing in the field of cardiovascular research and his commitment to scientific excellence. His work has earned the respect of colleagues and institutions alike, leading to numerous invitations to contribute to collaborative projects, serve on peer-review panels, and mentor future generations of cardiovascular researchers.

🌍 Impact and Influence

Dr. Cheng’s work has had a lasting impact on both experimental and clinical cardiology. By elucidating the mechanistic basis of ventricular dysfunction, he has helped shift paradigms in heart failure management, particularly in the areas of ventricular interdependence and preload responsiveness. His research findings are frequently cited in textbooks and high-impact journals, and they continue to inform guidelines for cardiac care and interventions. Through his work at Wake Forest and beyond, Dr. Cheng has played a pivotal role in bridging laboratory discoveries with bedside applications.

👨‍🏫 Legacy and Mentorship

As a respected mentor and educator, Dr. Cheng has dedicated a significant portion of his career to training medical students, residents, and postdoctoral fellows. His mentorship has influenced numerous emerging scholars in cardiovascular medicine, many of whom have gone on to successful academic and clinical careers. His guidance combines a rigorous scientific approach with a deep sense of responsibility to patient care and scientific integrity, shaping a legacy that extends well beyond his own research output.

🔬 Future Contributions and Vision

Looking ahead, Dr. Cheng remains committed to the advancement of cardiovascular research, with a continued focus on uncovering the cellular and mechanical determinants of heart disease. His vision includes fostering collaborative projects that integrate biomedical engineering, imaging, and computational modeling to further understand cardiac performance. With decades of experience and a forward-thinking approach, Dr. Cheng’s future contributions are poised to leave a lasting mark on the field of translational cardiovascular medicine.

Publication

  1. Title: Increased CaMKII activation and contrast changes of cardiac β1-and β3-Adrenergic signaling pathways in a humanized angiotensinogen model of hypertension
    Authors: Sun, Xiaoqiang; Cao, Jing; Chen, Zhe; Ferrario, Carlos M.; Cheng, Cheping
    Year: 2023
    Journal: Heliyon

 

  1. Title: Calmodulin-dependent protein kinase II activation promotes kidney mesangial expansion in streptozotocin-induced diabetic mice
    Authors: Mikhailov, Alexei V.; Liu, Yixi; Cheng, Hengjie; Lin, Jen Jar; Cheng, Cheping
    Year: 2022
    Journal: Heliyon

 

  1. Title: Chronic GPR30 agonist therapy causes restoration of normal cardiac functional performance in a male mouse model of progressive heart failure: Insights into cellular mechanisms
    Authors: Zhang, Xiaowei; Li, Tiankai; Cheng, Hengjie; Groban, Leanne; Cheng, Cheping
    Year: 2021
    Journal: Life Sciences

 

  1. Title: Chronic Ca2+/calmodulin-dependent protein Kinase II inhibition rescues advanced heart failure
    Authors: Liu, Yixi; Shao, Qun; Cheng, Hengjie; Zhao, David Xiao Ming; Cheng, Cheping
    Year: 2021
    Journal: Journal of Pharmacology and Experimental Therapeutics

 

  1. Title: The Angiotensin-(1–12)/Chymase axis as an alternate component of the tissue renin angiotensin system
    Authors: Ferrario, Carlos M.; Groban, Leanne; Wang, Hao; Sun, Xuming; Ahmad, Sarfaraz
    Year: 2021
    Journal: Molecular and Cellular Endocrinology

 

  1. Title: Reversal of angiotensin-(1–12)-caused positive modulation on left ventricular contractile performance in heart failure: Assessment by pressure-volume analysis
    Authors: Li, Tiankai; Zhang, Zhi; Zhang, Xiaowei; Ferrario, Carlos M.; Cheng, Cheping
    Year: 2020
    Journal: International Journal of Cardiology

 

  1. Title: Female Heart Health: Is GPER the Missing Link?
    Authors: Groban, Leanne; Tran, Q. K.; Ferrario, Carlos M.; Wang, Hao; Lindsey, Sarah H.
    Year: (Not specified, but likely 2020 or 2021)
    Journal: (Not specified)

 

🏁 Conclusion

Dr. Cheng’s legacy is one of intellectual rigor, clinical relevance, and mentorship. His work has not only deepened the scientific understanding of cardiac physiology but has also shaped modern approaches to diagnosing and managing heart failure. With a career spanning continents and disciplines, Dr. Cheng continues to be a guiding force in cardiovascular medicine, and his future contributions are anticipated to further advance the frontiers of heart research and patient care.

 

Hao Lai | Clinical Neuroscience | Best Researcher Award

Posted on by Neuroscientists

Prof. Dr. Hao Lai | Clinical Neuroscience | Best Researcher Award

Prof. Dr. Hao Lai, Zhongshan Hospital, Fudan University, China.

Dr. Hao Lai is a distinguished cardiovascular surgeon and researcher, currently serving as Chief Physician at Zhongshan Hospital, Fudan University. With over 20 years of clinical expertise, he specializes in aortic and cardiovascular surgery. His academic achievements include a Ph.D. in Surgery from Fudan University and significant contributions to the study of epigenetic mechanisms in thoracic aortic dissection. As a principal investigator of nationally funded projects and co-author of influential publications, Dr. Lai combines scientific rigor with clinical innovation. He has also played a key role in medical education and device development through industry collaboration.

Profile

Scopus

 

🎓 Early Academic Pursuits

Dr. Hao Lai began his academic journey with a strong foundation in medical sciences, culminating in a Ph.D. in Surgery from the prestigious Fudan University. His early academic pursuits were marked by a deep interest in cardiovascular physiology and surgical intervention, which later matured into a specialized focus on aortic diseases. His time as a doctoral candidate not only equipped him with rigorous scientific training but also ignited his lifelong commitment to solving complex clinical problems through research.

🏥 Professional Endeavors

Currently serving as Chief Physician at Zhongshan Hospital, Fudan University, Dr. Hao Lai has accumulated over two decades of extensive clinical experience in cardiovascular and aortic surgery. His professional trajectory reflects a seamless integration of surgical excellence with academic leadership. At Zhongshan Hospital, a leading institution in China, he has spearheaded several clinical programs aimed at enhancing patient outcomes in cases of thoracic aortic dissection and other high-risk cardiovascular conditions.

🔬 Contributions and Research Focus

Dr. Lai’s research centers around the epigenetic mechanisms underlying thoracic aortic dissection, with a particular focus on histone modification and DNA methylation. He is the Principal Investigator of a major research project funded by the National Natural Science Foundation of China, which explores the role of H3K36me3 histone modification and DNMT3B-mediated gene body methylation in the pathogenesis of aortic dissection. His scientific efforts bridge molecular pathology with clinical implications, offering new perspectives on the diagnosis and treatment of life-threatening vascular disorders.

🏆 Accolades and Recognition

A respected voice in cardiovascular medicine, Dr. Hao Lai has co-authored numerous influential articles in high-impact journals such as Cardiovascular Research and Advanced Science. His h-index of 18, as listed on Scopus, reflects his consistent scholarly output and the wide academic acknowledgment of his work. In addition, his authorship of the textbook Practical Surgery (3rd Edition), published by People’s Medical Publishing House, stands as a testament to his educational contributions to the next generation of Chinese surgeons.

🧪 Impact and Innovation

Dr. Lai’s research has made a tangible impact on the understanding and treatment of aortic diseases. His investigation into the epigenetic regulation of vascular pathology has opened new avenues for targeted therapies. Moreover, his collaboration with MicroPort Endovascular MedTech demonstrates his commitment to translating research findings into real-world applications, particularly in the development and refinement of endovascular surgical devices.

🌍 Influence and Collaboration

Beyond his direct research and surgical contributions, Dr. Lai’s influence extends into collaborative domains, both nationally and internationally. His leadership in high-level research grants, clinical trials, and industrial partnerships positions him as a central figure in the evolving landscape of cardiovascular surgery. His collaborative spirit fosters innovation and promotes cross-disciplinary dialogue, essential in today’s complex medical research environment.

🔮 Legacy and Future Contributions

As Dr. Hao Lai continues his distinguished career, his legacy is being shaped not only by his surgical accomplishments but also by his contributions to medical science. His ongoing projects are likely to further clarify the molecular landscape of aortic diseases and inspire new therapeutic strategies. Looking ahead, Dr. Lai is poised to remain at the forefront of cardiovascular innovation, committed to improving patient care through a synthesis of research, education, and clinical practice.

Publication

 

Title: Prevalence and predictors of left atrial thrombus in patients with rheumatic atrial fibrillation undergoing cardiac surgery: a cross-sectional study
Authors: J. Cui, Y. Zhang, Y. Wang, Q. Ji, C. Wang
Year: 2025


Title: A novel open-vascular single-branched stent graft in total arch repair of type A aortic dissection one-year results of a prospective multicenter randomized controlled study
Authors: J. Gu, W. Zhang, L. Kang, H. Lai, C. Wang
Year: 2025


Title: Fibroblast Activation Protein Acts as a Biomarker for Monitoring ECM Remodeling During Aortic Aneurysm via 68Ga-FAPI-04 PET Imaging
Authors: C. Hu, H. Tan, Y. Zhang, X. Chen, L. Wang
Year: 2025


Title: Mitochondrial NAD+ deficiency in vascular smooth muscle impairs collagen III turnover to trigger thoracic and abdominal aortic aneurysm
Authors: J. Zhang, Y. Tang, S. Zhang, K. Zhu, W. Zhang
Year: 2025


Title: Correcting mitochondrial loss mitigates NOTCH1-related aortopathy in mice
Authors: Y. Tang, J. Zhang, Y. Fang, Y. Xu, W. Zhang
Year: 2025


Title: Exploration of 68Ga-FAPI-04 PET/MR in Chronic Type B Aortic Dissection
Authors: C. Hu, Y. Zhang, S. Qiu, H. Shi, L. Wang
Year: 2025


Title: Effects of postoperative glucocorticoids on mitigation of organ dysfunction in patients with type A aortic dissection: A randomized controlled trial
Authors: M. Luo, J. Luo, X. Xu, G. Tu, Z. Luo
Year: 2024


Title: Therapeutic results of three-dimensional aortic valve anatomic repair for regurgitant bicuspid aortic valve
Authors: J. Li, C. Wang, Z. Zuo, W. Ding, T. Hong
Year: 2024


Title: 68Ga-FAPI-04 Positron Emission Tomography/Magnetic Resonance Imaging for Assessing Ascending Aortic Aneurysm
Authors: C. Hu, H. Tan, Y. Zhang, H. Lai, L. Wang
Year: 2024


Title: Sex-based outcomes after thoracic endovascular aortic repair: A systematic review and meta-analysis
Authors: Y. Zhang, Y. Zhang, Y. Wang, L. Wang, Q. Ji
Year: 2025

✅ Conclusion

Dr. Hao Lai’s career represents a powerful blend of surgical precision, scientific insight, and academic leadership. His work has advanced the understanding of aortic diseases at the molecular level while improving surgical outcomes for patients. As he continues to mentor, innovate, and lead research at the intersection of epigenetics and cardiovascular pathology, Dr. Lai’s contributions are set to leave a lasting legacy in both clinical practice and medical science.